Finance

Lists
AJANTPHARM:NSE
Ajanta Pharma Ltd
₹3 405,00
-0,89%
(-30,60) 1D
9 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AJANTPHARM...
Open
₹3 437,90
High
₹3 478,20
Low
₹3 364,40
Mkt. cap
426,12 mjd
Avg. vol.
86,93 k
Volume
124,42 k
Dividend
1,56%
Quarterly dividend
₹13,25
Ex-dividend date
05 Aug. 2026
P/E ratio
37,49
52-wk high
₹3 796,00
52-wk low
₹2 380,20
EPS
₹90,83
Shares outstanding
88,45 m
No. of employees
10 k
Open
₹3 437,90
High
₹3 478,20
Low
₹3 364,40
Mkt. cap
426,12 mjd
Avg. vol.
86,93 k
Volume
124,42 k
Dividend
1,56%
Quarterly dividend
₹13,25
Ex-dividend date
05 Aug. 2026
P/E ratio
37,49
52-wk high
₹3 796,00
52-wk low
₹2 380,20
EPS
₹90,83
Shares outstanding
88,45 m
No. of employees
10 k
News stories
From web sources and news partners
Profile
Ajanta Pharma Limited is an Indian multinational pharmaceutical company. The company operates in India, the United States, and over 30 countries across Africa, Southeast Asia, West Asia, and the CIS. It was established in 1973.. Wikipedia
About Ajanta Pharma Ltd
CEO-
Employees10,4 k
Founded1973
Headquarters-
SectorPharmaceutical industry
Last report
30 Jul. 2026
Fiscal period
Q1 2027
₹26,72 / ₹22,90
+16,68%beat
Revenue / Est. (INR)
16,26 mjd / 15,30 mjd
+6,26%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
13,54 mjd
13,75 mjd
14,22 mjd
16,26 mjd
Cost of goods sold
3,17 mjd
2,86 mjd
3,85 mjd
3,28 mjd
Cost of revenue
3,17 mjd
2,86 mjd
3,85 mjd
3,28 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,17 mjd
3,31 mjd
3,50 mjd
3,81 mjd
Operating expense
7,11 mjd
7,50 mjd
7,05 mjd
8,88 mjd
Total operating expenses
10,28 mjd
10,36 mjd
10,90 mjd
12,16 mjd
Operating income
3,26 mjd
3,39 mjd
3,32 mjd
4,10 mjd
Other non operating income
197,10 m
164,20 m
-447,90 m
204,30 m
EBT including unusual items
3,41 mjd
3,59 mjd
3,47 mjd
4,47 mjd
EBT excluding unusual items
3,41 mjd
3,59 mjd
4,42 mjd
4,47 mjd
Income tax expense
806,20 m
848,30 m
804,10 m
1,13 mjd
Effective tax rate
23,66%
23,66%
23,17%
25,20%
Other operating expenses
3,51 mjd
3,76 mjd
3,09 mjd
4,63 mjd
Net income
2,60 mjd
2,74 mjd
2,67 mjd
3,34 mjd
Net profit margin
19,22%
19,91%
18,76%
20,56%
Earnings per share
20,82
21,91
21,34
26,72
Interest and investment income
-
-
516,00 m
-
Interest expense
-33,90 m
-51,00 m
-23,60 m
-31,80 m
Net interest expenses
-33,90 m
-51,00 m
492,40 m
-31,80 m
Depreciation and amortization charges
429,70 m
435,10 m
453,70 m
445,00 m
EBITDA
3,68 mjd
3,70 mjd
3,70 mjd
4,49 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme